Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
33.50
Nov 20 • 3:59 PM ET Dollar change-0.79 Percentage change(-2.30%)
Aftermarket Close
34.17
Aftermarket • 7:51 PM ET Dollar change+0.67 Percentage change(2.00%)
Category
US Equities - Industry Sector
Sponsor
Elevate Shares
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
1.00%
Inverse/Leveraged
IPO
Oct 24, 2023
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-16.92%
SMA50
-16.27%
SMA200
36.86%
Return% 1Y
439.73%
Return% 3Y
17.90%
Return% 5Y
-
Return% 10Y
Return% SI
Flows% 1M
23.04%
Flows% 3M
69.52%
Flows% YTD
7.27%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
16
AUM
223.90M
NAV/sh
52W High
48.42 -30.82%
52W Low
13.60 146.32%
Volatility
6.55% 7.20%
ATR (14)
2.92
RSI (14)
35.08
Beta
0.21
Rel Volume
0.86
Avg Volume
360.28K
Volume
308,435
Perf Week
-13.39%
Perf Month
-14.30%
Perf Quarter
1.06%
Perf Half Y
116.69%
Perf YTD
127.89%
Perf Year
146.32%
Perf 3Y
-82.78%
Perf 5Y
-
Perf 10Y
-
Prev Close
34.29
Price
33.50
Change %
-2.30%
YieldMax MRNA Option Income Strategy ETF seeks current income; exposure to the share price of the common stock of Moderna, Inc. ("MRNA"), subject to a limit on potential investment gains is the secondary consideration. The fund advisor will seek to employ the fund's investment strategy as the fund relates to MRNA regardless of whether there are periods of adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods. The fund is non-diversified.